(Reuters) – A U.S. district court on Thursday ruled in favor of generic drugmaker Mylan NV in a patent dispute over Biogen Inc’s blockbuster
Tag - healthNews
(Reuters) – A U.S. district court on Thursday ruled in favor of generic drugmaker Mylan NV in a patent dispute over Biogen Inc’s blockbuster
The logo of U.S. pharmaceutical corporation Pfizer Inc. is seen at a branch in Zurich, Switzerland October 2, 2018. REUTERS/Arnd Wiegmann (Reuters) –
NEW YORK/LOS ANGELES (Reuters) – Raising black boys in America involves “constant mental anguish,” Danielle Pattillo, a special education
(Reuters) – Airspace Systems, a California startup company that makes drones that can hunt down and capture other drones, on Thursday released new
BRUSSELS (Reuters) – German victims of defective breast implants made by French company Poly Implant Prothese (PIP) cannot claim damages from its insurer
NEW YORK (Reuters) – New York state filed civil charges on Wednesday accusing Endo International Plc of insurance fraud for misrepresenting the safety
LONDON (Reuters) – Scientists have used human embryonic stem cells to create an embryo-like research model to help them study some of the earliest stages
FRANKFURT (Reuters) – Britain’s AstraZeneca will continue to look for more production partners for the experimental vaccine it is working on with
LONDON (Reuters) – The GAVI vaccines alliance said on Thursday it had raised $8.8 billion from international donor governments, companies and
